← Leaderboards
Donald J. Tindall
Mayo Clinic Coll Of Medicine, Rochester
$5,698,348
Attributed
$5,698,348
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2005–11$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$29,119,658 · 9
By mechanism
P50$24,451,166 · 4
R01$4,511,177 · 4
U54$157,315 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Brian J Davis$2,134,733
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateResearch PersonnelProgramsAndrogen ReceptorProstateAndrogensProstate NeoplasmsCellsGrowthMediatingProteinsPlayAblationTumorAffectCancer CellMaleMolecularBaseEp300 GeneResearch Project GrantsMetastatic Prostate CancerReproduction SporesClinic
Grant awards (40)
Androgenic Inactivation of FOXO1 in Prostate Cancer$255,475
R01 · FY2011 · CA · contact PI
SPORE in Prostate Cancer$2,179,681
P50 · FY2010 · CA · contact PI
Coregulators in Androgen-Refractory Prostate Cancer$264,063
R01 · FY2010 · CA · contact PI
Androgenic Inactivation of FOXO1 in Prostate Cancer$263,376
R01 · FY2010 · CA · contact PI
Administrative Core$201,435
P50 · FY2010 · CA · contact PI
Developemental Research Program$121,796
P50 · FY2010 · CA · contact PI
Career Development Program$60,897
P50 · FY2010 · CA · contact PI
SPORE in Prostate Cancer$2,179,681
P50 · FY2009 · CA · contact PI
Coregulators in Androgen-Refractory Prostate Cancer$264,063
R01 · FY2009 · CA · contact PI
Androgenic Inactivation of FOXO1 in Prostate Cancer$263,376
R01 · FY2009 · CA · contact PI
Administrative Core$201,435
P50 · FY2009 · CA · contact PI
Developemental Research Program$121,796
P50 · FY2009 · CA · contact PI
Career Development Program$60,897
P50 · FY2009 · CA · contact PI
SPORE in Prostate Cancer$2,179,681
P50 · FY2008 · CA · contact PI
Coregulators in Androgen-Refractory Prostate Cancer$264,063
R01 · FY2008 · CA · contact PI
Androgenic Inactivation of FOXO1 in Prostate Cancer$263,376
R01 · FY2008 · CA · contact PI
Administrative Core$127,250
P50 · FY2008 · CA · contact PI
Developemental Research Program$89,567
P50 · FY2008 · CA · contact PI
Career Development Program$44,783
P50 · FY2008 · CA · contact PI
SPORE in Prostate Cancer$2,277,704
P50 · FY2007 · CA · contact PI
Coregulators in Androgen-Refractory Prostate Cancer$264,063
R01 · FY2007 · CA · contact PI
Androgenic Inactivation of FOXO1 in Prostate Cancer$263,376
R01 · FY2007 · CA · contact PI
SPORE in Prostate Cancer$2,244,780
P50 · FY2006 · CA · contact PI
Coregulators in Androgen-Refractory Prostate Cancer$271,950
R01 · FY2006 · CA · contact PI
Androgenic Inactivation of FKHR in Prostate Cancer$249,496
R01 · FY2006 · DK · contact PI
SPORE in Prostate Cancer$104,531
P50 · FY2006 · CA · contact PI
SPORE in Prostate Cancer$57,958
P50 · FY2006 · CA · contact PI
SPORE in Prostate Cancer$2,555,905
P50 · FY2005 · CA
Androgenic Inactivation of FKHR in Prostate Cancer$255,500
R01 · FY2005 · DK
SPORE in Prostate Cancer$2,476,722
P50 · FY2004 · CA
Androgenic Inactivation of FKHR in Prostate Cancer$255,500
R01 · FY2004 · DK
Coactivators in Androgen-Refractory Prostate Cancer$214,500
R01 · FY2004 · DK
SPORE in Prostate Cancer$2,513,374
P50 · FY2003 · CA
Androgenic Inactivation of FKHR in Prostate Cancer$255,500
R01 · FY2003 · DK
Coactivators in Androgen-Refractory Prostate Cancer$214,500
R01 · FY2003 · DK
SPORE in Prostate Cancer$2,575,818
P50 · FY2002 · CA
Coactivators in Androgen-Refractory Prostate Cancer$214,500
R01 · FY2002 · DK
SPORE in Prostate Cancer$2,075,475
P50 · FY2001 · CA
Coactivators in Androgen-Refractory Prostate Cancer$214,500
R01 · FY2001 · DK
CHARACTERIZATION OF EARLY GROWTH RESPONSE GENES IN PROSTATE CELLS$157,315
U54 · FY2000 · HD